Hide metadata

dc.date.accessioned2020-07-09T18:28:52Z
dc.date.available2020-07-09T18:28:52Z
dc.date.created2020-01-30T16:20:08Z
dc.date.issued2019
dc.identifier.citationBernabe, Rosemarie de la Cruz van Thiel, Ghislaine JMW Breekveldt, Nancy S Gispen, Christine C Van Delden, Johannes JM . Regulatory sanctions for ethically relevant GCP violations. Drug Discovery Today. 2019, 24(11), 2116-2119
dc.identifier.urihttp://hdl.handle.net/10852/77698
dc.description.abstractAlthough EU inspectors and clinical assessors are mandated to identify and act upon ethical issues, regulators lack guidance on how this can be done. Hence, we propose a four-step regulatory approach on ethically relevant GCP violation findings. The first step is identification of the ethical issue. Next is analysis [i.e., identifying the gravity (intensity or severity) and the magnitude (amount and duration) of the ethics violation as well as the responsible person(s) or entity or entities]. The third step is evaluation, (i.e., the process of deliberating to determine the significance of the ethics violation, with the intention of identifying the most reasonable sanction and/or corrective or reparative action). Last is decision-making or the process of choosing and implementing a regulatory course of action.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleRegulatory sanctions for ethically relevant GCP violationsen_US
dc.typeJournal articleen_US
dc.creator.authorBernabe, Rosemarie de la Cruz
dc.creator.authorvan Thiel, Ghislaine JMW
dc.creator.authorBreekveldt, Nancy S
dc.creator.authorGispen, Christine C
dc.creator.authorVan Delden, Johannes JM
cristin.unitcode185,52,13,0
cristin.unitnameSenter for medisinsk etikk
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1786990
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Drug Discovery Today&rft.volume=24&rft.spage=2116&rft.date=2019
dc.identifier.jtitleDrug Discovery Today
dc.identifier.volume24
dc.identifier.issue11
dc.identifier.startpage2116
dc.identifier.endpage2119
dc.identifier.doihttps://doi.org/10.1016/j.drudis.2019.07.001
dc.identifier.urnURN:NBN:no-80807
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1359-6446
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/77698/2/Regulatory%2Bsanctions%2Bfor%2Bethically%2Brelevant%2BGCP%2Bviolations.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International